Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
8 hedge funds and large institutions have $490K invested in Altamira Therapeutics Ltd in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
1,481% more capital invested
Capital invested by funds: $31K → $490K (+$459K)
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
100% more funds holding
Funds holding: 4 → 8 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$103K |
| 2 |
Renaissance Technologies
New York
|
+$102K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$34.8K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$19.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$19K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $167K | +$103K | +160 | New |
|
|
2
Renaissance Technologies
New York
| $165K | +$102K | +158 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $56K | +$34.8K | +54 | New |
|
|
4
Envestnet Asset Management
Chicago,
Illinois
| $33K | +$19.9K | +31 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| $26K | +$16.1K | +25 | New |
|
|
SFS
6
Sowell Financial Services
North Little Rock,
Arkansas
| $22K | +$13.5K | +21 | New |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $11K | +$2.57K | +4 | +67% |
|
8
Wells Fargo
San Francisco,
California
| $10K | +$6.44K | +10 | New |
|
|
HF
9
HRT Financial
New York
| – | -$19K | -60 | Closed |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$10K | -31 | Closed |
|
CYTO Hedge Fund Activity: Q4 2020 in Review
8 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q4 2020, worth a combined $490K — up 1,481% from $31K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CYTO positions and 3 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $103K. The largest seller was HRT Financial, exiting entirely with an estimated $19K sold.
- 8 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q4 2020, up from 4 in Q3 2020.
- Funds reported $490K of Altamira Therapeutics Ltd stock for Q4 2020, up 1,481% quarter-over-quarter.
- 7 funds opened new Altamira Therapeutics Ltd positions in Q4 2020 and 3 closed out, a net change of +4 holders.
- The largest Altamira Therapeutics Ltd buyer in Q4 2020 was Virtu Financial, an estimated $103K added.
- The largest Altamira Therapeutics Ltd seller in Q4 2020 was HRT Financial, an estimated $19K sold.
Based on aggregated 13F filings for Q4 2020.